<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03499431</url>
  </required_header>
  <id_info>
    <org_study_id>001</org_study_id>
    <nct_id>NCT03499431</nct_id>
  </id_info>
  <brief_title>Longitudinal Registry of Endovascular Thoracoabdominal Aneurysms</brief_title>
  <acronym>LoRETA</acronym>
  <official_title>Longitudinal Registry of Endovascular Thoracoabdominal Aneurysms: Study of Fenestrated and Branched Stent Grafts in the Treatment of Aortic Aneurysms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tara Mastracci</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Lille</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Skane University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Royal Free Hospital NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the long-term safety and performance of complex
      endovascular aneurysm repair by inclusion in a longitudinal registry
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a Global, multicenter, prospective, observational, non-randomized, single-arm, open
      clinical study will evaluate the long term (i.e. &gt;5 years) safety and efficacy of complex
      endovascular repair

      This study will enroll all patients treated with Fenestrated and Branched devices in Europe
      and Canada that follow all inclusion criteria and none of the exclusion criteria. The total
      duration of the study will be of approximately 7 years.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 30, 2018</start_date>
  <completion_date type="Anticipated">March 2023</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>7 Years</target_duration>
  <primary_outcome>
    <measure>Longterm Aneurysm Related Mortality</measure>
    <time_frame>7 years</time_frame>
    <description>Death attributed to aneurysm rupture</description>
  </primary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Aneurysm</condition>
  <condition>Aortic Aneurysm</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endovascular Thoracoabdominal Aneurysm Repair</intervention_name>
    <description>Standard of care, treatment of thoracoabdominal aneurysms using endovascular techiniques.</description>
    <other_name>Branched and Fenestrated Devices</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients undergoing complex EVAR at study sites.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient eligibility for enrolment shall be based on known information at the time of
             the procedure. Information obtained at a later date may contradict these criteria, but
             this will not be considered a deviation of the Study Plan.

        Inclusion criteria

        A patient is deemed suitable for inclusion in the study if the patient meets both of the
        following criteria:

          1. Patient requires endovascular repair of a thoracic, thoraco-abdominal or abdominal
             aortic or aorto-iliac aneurysm having morphology suitable for endovascular repair with
             complex endograft.

          2. Patients (or their legal representative for minor patients) who do not object to (oral
             non-objection declaration, and signed consent form) collection and transmission of
             his/her data.

        Exclusion Criteria:

          -  Patients are excluded from enrolment into the study if any of the following are true:

               1. Patients whose imaging follow-up is impossible, i.e. patients who are not able to
                  send their follow up CT scans or Duplex US
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 9, 2018</study_first_submitted>
  <study_first_submitted_qc>April 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2018</study_first_posted>
  <last_update_submitted>April 9, 2018</last_update_submitted>
  <last_update_submitted_qc>April 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Royal Free Hospital NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>Tara Mastracci</investigator_full_name>
    <investigator_title>Co-Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

